View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMynaric 배당 및 자사주 매입배당 기준 점검 0/6Mynaric 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-171.3%자사주 매입 수익률총 주주 수익률-171.3%미래 배당 수익률0%배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 01Mynaric AG announced delayed 20-F filingOn 04/30/2025, Mynaric AG announced that they will be unable to file their next 20-F by the deadline required by the SEC.공시 • Mar 30Mynaric AG Announces Resignation of Bulent Altan as Chairman and Member of Supervisory Board Effective April 1, 2025Mynaric AG announced that Bulent Altan, on March 28, 2025, has tendered his resignation as Chairman and Member of the Supervisory Board of the Company for personal reasons effective April 1, 2025. Bulent Altan was elected Chairman of the Supervisory Board of the Company following his election as member of the Supervisory Board by the General Assembly in August 2023. The Supervisory Board of the Company will conduct a new election for the role of Chairman without undue delay. A new member will be appointed in due course in accordance with the provisions of applicable stock corporation act (Aktiengesetz).공시 • Mar 13Rocket Lab USA, Inc. (NasdaqCM:RKLB) entered into a non-binding term sheet to acquire Mynaric AG (XTRA:M0YN) from Lenders for $150 million.Rocket Lab USA, Inc. (NasdaqCM:RKLB) entered into a non-binding term sheet to acquire Mynaric AG (XTRA:M0YN) from Lenders for $150 million on March 10, 2025. As part of the acquisition, Rocket Lab would acquire 100% of the outstanding equity interests of Mynaric and initial purchase price is expected to be $75 million payable in either cash or shares of common stock of Rocket Lab, at Rocket Lab’s option, with the potential for additional earn-out consideration based on future revenue targets of the Mynaric business of up to an additional $75 million in shares of Rocket Lab common stock or cash, at Rocket Lab’s option. The initial closing purchase price will also be increased (and the potential earnout consideration correspondingly decreased) to the extent of any additional cash investment by the Lenders or their affiliates in Mynaric after completion of the StaRUG Restructuring and before the closing of the potential acquisition. If Rocket Lab USA, Inc chooses to issue cash consideration, then the proceeds from the offering will be used to fund the acquisition. The transaction is subject to receipt of certain governmental approvals, following the completion of Mynaric’s previously announced and pending StaRUG restructuring proceedings under German law, the completion of which would result in certain outstanding debt held by the Lenders converting into 100% of the equity of Mynaric, subject to customary due diligence and signing of definitive agreement.공시 • Mar 12Mynaric Updates on Operational Continuity and Ongoing Production and DeliveriesMynaric announced that it is continuing to ramp up production and customer deliveries of the CONDOR Mk3 optical communications terminal and updates on the background to the company’s StaRUG proceedings. The StaRUG proceedings, once completed, would provide for significant debt relief, enabling the company to continue to serve its current and potential customers, suppliers and partners. Focus on Delivering on Existing Contracts and Winning Future Opportunities: Mynaric is also continuing to pursue opportunities that explore the use of free-space optical communications for additional space programs. In addition to contributing to the U.S. Space Development Agency’s (SDA) Proliferated Warfighter Space Architecture (PWSA) Tranche 1 and Tranche 2 programs, Mynaric has also been recognized as a key development partner in multiple projects to develop quantum communication capabilities. Establishing a Stable Financial and Operational Footing Moving Forward: Mynaric’s lenders agreed to the restructuring concept on the condition that Mynaric initiates StaRUG proceedings and that the restructuring plan provides for a capital reduction to zero. To enable Mynaric to cover its expected ongoing operational and working capital until the conclusion of the StaRUG proceedings, Mynaric’s lenders committed a fourth bridge loan of USD 28 million in February 2025 as well as an additional USD 25 million restructuring loan, giving Mynaric the necessary resources to support its production plan and ongoing operations. The implementation of the financial restructuring through the StaRUG proceedings would safeguard jobs, protect creditor interests, and significantly reduce Mynaric’s cash interest burden.공시 • Feb 18+ 1 more updateMynaric AG(NasdaqGS:MYNA) dropped from NASDAQ Composite IndexMynaric AG has been dropped from the NASDAQ Composite Index.공시 • Feb 14Mynaric Announces Receipt of Delisting Notice from NasdaqMynaric announced that it received a delisting notification dated February 10, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market Inc. As previously disclosed, on February 7, 2025, Mynaric's management board, with the approval of its supervisory board, resolved on a financial restructuring by proceedings under the German Corporate Stabilization and Restructuring Act (Gesetz über den Stabilisierungs- und Restrukturierungsrahmen für Unternehmen) and notified the competent Munich Local Court - Restructuring Court - of such restructuring project (the "StaRUG Proceeding").On February 10, 2025, Mynaric received the Delisting Notice from Nasdaq notifying Mynaric that, as a result of the StaRUG Proceeding and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined that Mynaric's American Depositary Shares representing its ordinary shares (the "ADS") will be delisted from Nasdaq. The Delisting Notice also advises Mynaric of its right to appeal Nasdaq's determination pursuant to procedures set in the Nasdaq Listing Rule 5800 Series. Mynaric does not intend to pursue an appeal. Trading of the ADS will be suspended at the opening of business on February 18, 2025. Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission, which will remove the ADS from listing and registration on Nasdaq. Nasdaq has previously notified Mynaric that it is no longer in compliance with (i) Nasdaq Listing Rule 5450(b)(2)(A) for failing to maintain a minimum market value of $50 million in listed securities, (ii) Nasdaq Listing Rule 5250(c)(2) for not filing an interim balance sheet and income statement as of and for the end of its second quarter on Form 6-K within six months following the end of Mynaric's second quarter, (iii) Nasdaq Listing Rule 5620(a) for failing to hold an annual meeting of shareholders within twelve months after the end of the Mynaric's fiscal year, and (iv) Nasdaq Listing Rule 5450(a)(1) for not meeting the minimum closing bid price of $1.00 per share of the ADS.New Risk • Feb 05New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.38m (US$9.77m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (36% average weekly change). Negative equity (-€49m). Market cap is less than US$10m (€9.38m market cap, or US$9.77m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Currently unprofitable and not forecast to become profitable over next 3 years (€22m net loss in 3 years).공시 • Jan 16Mynaric AG, Annual General Meeting, Feb 21, 2025Mynaric AG, Annual General Meeting, Feb 21, 2025, at 10:00 W. Europe Standard Time.공시 • Jan 04Mynaric AG Updates Earnings Guidance for the Full Year 2024Mynaric AG updated earnings guidance for the full year 2024. For the year, the company anticipates IFRS-15 revenue of EUR 14.1 million compared to previous guidance of a range estimating between EUR 16.0 million to EUR 24.0 million. The guidance decrease reflects shipments of CONDOR Mk3 terminals, originally expected to ship in late 2024, to slip into early 2025, due to shortages of key components from suppliers. These delays resulted in approximately EUR 2.6 million of revenue for terminals previously expected to ship in 2024 now expected to ship and revenue recognized in early 2025. Operating loss: the previous Company guidance of a range of operating loss estimating to range between a loss of EUR 55.0 million to EUR 50.0 million is unchanged.New Risk • Dec 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Negative equity (-€49m). Market cap is less than US$10m (€7.90m market cap, or US$8.29m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€48m net loss in 2 years).New Risk • Dec 06New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.72m (US$9.21m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Negative equity (-€49m). Market cap is less than US$10m (€8.72m market cap, or US$9.21m). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€46m net loss in 2 years).공시 • Nov 05Mynaric AG, Annual General Meeting, Dec 11, 2024Mynaric AG, Annual General Meeting, Dec 11, 2024, at 10:00 W. Europe Standard Time.공시 • Nov 01Bronstein, Gewirtz & Grossman, LLC Announces Class Action Lawsuit Files Against Mynaric AGBronstein, Gewirtz & Grossman, LLC announced that a class action lawsuit has been filed against Mynaric AG (Mynaric) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mynaric securities between June 20, 2024, and October 7, 2024, inclusive (Class Period). The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) lower-than-expected production yields and component supplier shortages of key components were causing production delays for Mynaric's CONDOR Mk3 product; (2) the foregoing issues were likely to have a material negative impact on the Company's revenue growth and cause the Company to incur an operating loss; (3) as a result, Mynaric was unlikely to meet its own previously issued financial guidance for fiscal year 2024; (4) accordingly, the Company's business and/or financial prospects were overstated; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times.공시 • Oct 08Mynaric Receives Deficiency Letter from Nasdaq Regarding Non-Compliance with the Minimum Market Value of Listed SecuritiesMynaric AG announced that it received a notification letter dated October 2, 2024 (the ‘Deficiency Letter’) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the ‘Nasdaq’) notifying that Mynaric is no longer in compliance with the Nasdaq continued listing criteria, including the Nasdaq Listing Rule 5450(b)(2)(A) due to its failure to maintain a minimum of $50 million in market value of listed securities (the ‘MVLS Requirement’). Nasdaq also determined that Mynaric does not meet the alternatives of total assets and total revenue for continued listing. The Deficiency Letter has no immediate effect on the listing of Mynaric’s American Depositary Shares representing its ordinary shares (the ‘ADS’), which continue to trade under the symbol ‘MYNA.’ The Deficiency Letter provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C), Mynaric has a period of 180 calendar days from the date of the Deficiency Letter, or until March 31, 2025, to regain compliance with the MVLS Requirement. During this period, the ADS will continue to trade on Nasdaq. Nasdaq will deem Mynaric to have regained compliance with the MVLS Requirement if at any time during this compliance period Mynaric’s MVLS closes at $50,000,000 or more for a minimum of ten consecutive business days. In the event Mynaric does not regain compliance with the MVLS Requirement by March 31, 2025, Mynaric will receive written notification from Nasdaq that Mynaric’s ADS are subject to delisting. At that time, Mynaric may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance, if Mynaric does appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would be successful. In such event, Mynaric may also seek to apply for a transfer to The Nasdaq Capital Market if it meets the requirements for continued listing thereon. Mynaric is reviewing its options for regaining compliance with the MVLS Requirement and for remedying other future potential non-compliances with Nasdaq continued listing requirements. There can be no assurance that Mynaric will be able to regain compliance with the MVLS Requirement or other Nasdaq continued listing requirements in a timely fashion, in which case its securities would be delisted from Nasdaq.공시 • Sep 17Mynaric Advances Production of CONDOR Mk3Mynaric announced the successful advancement of the company's volume production ramp for the CONDOR Mk3. Mynaric continues to work through previously announced production delays and has realized near-term improvement in production yields and supply chain-related bottlenecks. Production delays of CONDOR Mk3 were caused by lower than expected production yields and supplier shortages of key components. Current shipments of the CONDOR Mk3 free space optical communications system will be part of the United States Space Development Agency (SDA) Tranche 1 program. Mynaric was selected by Northrop Grumman as the sole supplier of optical communications terminals for the SDA's Tranche 1 Transport and Tracking Layer programs and by York Space Systems for the SDA's Tranche 1 Transport Layer. Mynaric was also selected by Loft Federal to supply the CONDOR Mk3 terminals to NExT – the SDA's Experimental Testbed. In addition, Mynaric continues to pursue opportunities that explore the use of free-space optical communications for additional space programs. Mynaric has been recognized as a key development partner in Phase 2 of DARPA's Space-BACN program, was selected by the European Space Agency (ESA) to investigate optical technologies for next generation high-throughput optical inter-satellite links and was selected by the German government for multiple projects to develop quantum communication capabilities. In addition, Mynaric continues to diligently pursue additional capital sources to secure on-going operations and production ramp.New Risk • Sep 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -€34m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€34m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Negative equity (-€49m). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€46m net loss in 2 years). Market cap is less than US$100m (€19.6m market cap, or US$21.7m).New Risk • Aug 30New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €94m Forecast net loss in 2 years: €46m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-€49m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-€34m). Currently unprofitable and not forecast to become profitable over next 2 years (€46m net loss in 2 years). Market cap is less than US$100m (€21.7m market cap, or US$24.1m).공시 • Aug 27+ 1 more updateMynaric AG Announces Management ChangesThe board of Mynaric AG announced the appointment of Andreas Reif with immediate effect as member of the management board and Chief Restructuring Officer. In his role as CRO, Andreas Reif will be integral to reducing costs and near-term cash consumption while working closely with customers to meet their requirements. Prior to joining Mynaric, Andreas Reif served in executive financial and operational roles and as a key advisor forindustrial manufacturing companies throughout Germany. Mynaric announced that the supervisory board and the chief executive officer, Mustafa Veziroglu, jointly decided on the termination of the office of Mustafa Veziroglu as CEO and member of the management board of Mynaric with immediate effect.Major Estimate Revision • Aug 23Consensus EPS estimates fall by 36%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €56.6m to €55.6m. Losses expected to increase from €7.53 per share to €10.24. Aerospace & Defense industry in Germany expected to see average net income growth of 35% next year. Consensus price target down from €31.50 to €20.40. Share price fell 68% to €4.55 over the past week.New Risk • Aug 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-€49m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-€34m). Market cap is less than US$100m (€44.1m market cap, or US$49.1m).공시 • Aug 20+ 1 more updateMynaric Announces Departure of Stefan Berndt Von-Bülow as CFOMynaric announced the voluntary departure of CFO Stefan Berndt von-Bülow for personal reasons, effective last week. Berndt von-Bülow has been with Mynaric since 2018 and assumed the role as CFO in 2020. As CFO, Berndt von-Bülow made significant contributions to the company's financial strategy and operations, investor relations, several capital raises, significant debt financing, and, particularly Mynaric's listing on Nasdaq in November 2021, during a time of significant growth and transformation. Mynaric has initiated a global search for a new CFO. In the interim, the two remaining members of the management team, Mustafa Veziroglu and Joachim Horwath, will assume the responsibilities of the CFO.Price Target Changed • Jul 30Price target decreased by 29% to €31.50Down from €44.50, the current price target is an average from 2 analysts. New target price is 109% above last closing price of €15.10. Stock is down 30% over the past year. The company is forecast to post a net loss per share of €7.52 next year compared to a net loss per share of €15.48 last year.공시 • Jul 23Mynaric AG, Annual General Meeting, Aug 29, 2024Mynaric AG, Annual General Meeting, Aug 29, 2024, at 10:00 W. Europe Standard Time.공시 • Jun 21Mynaric Provides Earnings Guidance for the Full Year 2024Mynaric provided earnings guidance for the full year 2024. For the fiscal year 2024, revenue outlook is driven by shipments of CONDOR Mk3 units to multiple customers. This outlook assumes it is able to ramp to its current production plans. This outlook remains at the lower end of the most recent published analyst estimates for 2024 (for which the arithmetic average is approximately €65 million). The company expects its operating loss for the fiscal year 2024 to decrease significantly from last year's level due to higher revenue levels. This outlook remains in-line with the most recent published analyst estimates for 2024 (for which the arithmetic average is approximately -€36 million). The outlook is based on the current projected production ramp and current liquidity projection. Should Mynaric experience either a pushout in its production schedule, fail to secure new orders as planned or incur delays in securing new orders from customers, there is a high likelihood the company could need to raise additional capital. Mynaric is also considering pursuing multiple alternative options in order to secure its cash needs and bolster its long-term success.공시 • Jun 14Mynaric AG to Report Fiscal Year 2023 Results on Jun 20, 2024Mynaric AG announced that they will report fiscal year 2023 results on Jun 20, 2024공시 • May 01Mynaric AG announced delayed 20-F filingOn 04/30/2024, Mynaric AG announced that they will be unable to file their next 20-F by the deadline required by the SEC.New Risk • Apr 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€23m net loss in 2 years). Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding).Major Estimate Revision • Apr 14Consensus revenue estimates fall by 61%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €11.0m to €4.30m. Forecast losses increased from -€11.81 to -€13.12 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 50% next year. Consensus price target down from €42.00 to €41.00. Share price rose 10% to €18.65 over the past week.공시 • Apr 03Mynaric Begins Volume Production for its Space Laser Terminal - CONDOR Mk3Mynaric announced a milestone in the product maturity of the company's free space optical communications terminal for space-to-space and space-to-ground applications - the CONDOR Mk3. Volume production for the optical communications terminal began early in the first quarter of 2024 with an initial shipment made last week following customer approval. Initial shipments of the CONDOR Mk3 free space optical communications system will be part of the United States Space Development Agency (SDA) Tranche 1 Transport and Tracking Layer programs, among others. Mynaric was selected by Northrop Grumman as the sole supplier of optical communications terminals for the SDA's Tranche 1 Transport and Tracking Layer programs and by York Space Systems for the SDA's Tranche 1 Transport Layer. Mynaric was also selected by Loft Federal to supply the CONDOR Mk3 terminals to NExT – the SDA's Experimental Testbed. In addition to volume production of the CONDOR Mk3 optical communications system, Mynaric continues to pursue opportunities that explore the use of free space optical communications for additional space programs. Mynaric has been recognized as a key development partner in Phase 2 of DARPA's Space-BACN program, was selected by the European Space Agency (ESA) to investigate optical technologies for next generation high-throughput optical inter-satellite links and was selected by the German government for multiple projects to develop quantum communication capabilities.Major Estimate Revision • Dec 15Consensus revenue estimates fall by 41%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €18.5m to €11.0m. Forecast losses increased from -€10.58 to -€11.81 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 35% next year. Consensus price target of €42.00 unchanged from last update. Share price rose 31% to €24.00 over the past week.Major Estimate Revision • Nov 19Consensus revenue estimates fall by 27%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €25.5m to €18.5m. Forecast losses increased from -€9.67 to -€10.58 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 44% next year. Consensus price target of €42.00 unchanged from last update. Share price fell 11% to €16.70 over the past week.공시 • Nov 12Mynaric Provides Earnings Guidance for the Full Year 2023Mynaric provides earnings guidance for the full year 2023. The company now expects full-year 2023 IFRS-15 revenue to remain around the same level as 2022 revenue of EUR 4.4 million compared to previous guidance of a significant increase. The guidance decrease is due to the production delay of CONDOR Mk3 that was previously scheduled to start in fourth quarter 2023. The company now expects full-year 2023 operating loss to be around the same level as last year compared to previous guidance of a moderate decrease relative to the EUR 73.8 million operating loss reported for full-year 2022.New Risk • Oct 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.5% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€25m net loss in 2 years). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (€89.1m market cap, or US$94.4m).New Risk • Oct 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.1m (US$94.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€25m net loss in 2 years). Share price has been volatile over the past 3 months (7.5% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (€90.1m market cap, or US$94.9m).Reported Earnings • Sep 17First half 2023 earnings released: €5.55 loss per share (vs €6.28 loss in 1H 2022)First half 2023 results: €5.55 loss per share (improved from €6.28 loss in 1H 2022). Net loss: €32.4m (loss narrowed 1.4% from 1H 2022). Revenue is forecast to grow 53% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Aerospace & Defense industry in Germany. Over the last 3 years on average, earnings per share has fallen by 34% per year whereas the company’s share price has fallen by 39% per year.New Risk • Sep 15New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €73m Forecast net loss in 2 years: €21m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€21m net loss in 2 years). Share price has been volatile over the past 3 months (6.2% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding).공시 • Sep 08Mynaric AG to Report First Half, 2023 Results on Sep 14, 2023Mynaric AG announced that they will report first half, 2023 results on Sep 14, 2023Price Target Changed • Sep 07Price target decreased by 21% to €36.67Down from €46.67, the current price target is an average from 3 analysts. New target price is 101% above last closing price of €18.20. Stock is down 36% over the past year. The company is forecast to post a net loss per share of €9.28 next year compared to a net loss per share of €13.57 last year.공시 • Aug 09Mynaric Announces Executive ChangesMynaric announced key results of the company's annual general assembly held on August 7, 2023. Following shareholder approval, industry veterans Bulent Altan and Margaret Abernathy joined Mynaric's Supervisory Board after receiving the requisite number of votes during the annual general assembly. They join the three re-elected Supervisory Board members: Dr. Hans Königsmann, Dr. Manfred Krischke, and Peter Müller-Brühl, effective immediately. Following the company's annual general assembly meeting, the Supervisory Board met and elected Bulent Altan as Chairman. Mustafa Veziroglu will serve as the company's Chief Executive Officer. Veziroglu will lead Mynaric's day-to-day business operations and strategy to produce laser communications terminals at scale for applications in space, air and terrestrial applications.공시 • Jul 01Mynaric AG, Annual General Meeting, Aug 07, 2023Mynaric AG, Annual General Meeting, Aug 07, 2023, at 10:00 Central European Standard Time. Location: Haus der Bayrischen Wirtschaft, Max-Joseph-Strasse 5, 80333 Munich, Germany Munich Germany Agenda: To consider Annual Financial Statement as of December 31, 2022; to consider Curriculum vitae of the candidates proposed for election to the Supervisory Board; and to consider other business matters.공시 • May 12+ 1 more updateMynaric Ag Announces Resignation of Mr. Altan as A Member of the Management BoardMynaric AG announced that Mr. Altan will resign from his position as member of the Management Board of Mynaric AG as of the end of the Annual General Meeting 2023 of the Company at the beginning of Third Quarter 2023.Price Target Changed • May 03Price target decreased by 13% to €51.17Down from €59.00, the current price target is an average from 3 analysts. New target price is 105% above last closing price of €24.90. Stock is down 30% over the past year. The company is forecast to post earnings per share of €2.94 next year compared to a net loss per share of €13.57 last year.Breakeven Date Change • May 01Forecast breakeven date moved forward to 2023The 4 analysts covering Mynaric previously expected the company to break even in 2025. New consensus forecast suggests the company will make a profit of €12.0m in 2023. Earnings growth of 44% is required to achieve expected profit on schedule.공시 • Feb 01+ 1 more updateMynaric AG Appoints Mustafa Veziroglu as Co-CEO, Effective February 1, 2023Mynaric, AG announced the appointment of Mustafa Veziroglu as Co-CEO of the company, effective February 1, 2023. Mustafa Veziroglu joined Mynaric in August 2022 as President and since then has been responsible for all operational product-related activities within Mynaric overseeing the entire product lifecycle from development through delivery. With Mynaric's recent success in winning additional new customers and hitting important customer milestones, his role as Co-CEO will be to strengthen Mynaric's focus on 2023 execution targets and jointly lead the company with Co-CEO Bulent Altan.Major Estimate Revision • Jan 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €2.26m to €2.99m. EPS estimate unchanged at -€11.66. Aerospace & Defense industry in Germany expected to see average net income growth of 43% next year. Consensus price target down from €59.00 to €52.00. Share price rose 11% to €15.30 over the past week.Major Estimate Revision • Nov 25Consensus revenue estimates fall by 56%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from €5.13m to €2.24m. Forecast losses increased from -€11.33 to -€11.54 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 42% next year. Consensus price target of €59.00 unchanged from last update. Share price was steady at €16.80 over the past week.Price Target Changed • Nov 16Price target decreased to €59.00Down from €71.00, the current price target is an average from 4 analysts. New target price is 249% above last closing price of €16.90. Stock is down 75% over the past year. The company is forecast to post a net loss per share of €3.90 next year compared to a net loss per share of €10.70 last year.Breakeven Date Change • Nov 16Forecast to breakeven in 2023The 3 analysts covering Mynaric expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of €12.0m in 2023. Average annual earnings growth of 50% is required to achieve expected profit on schedule.Major Estimate Revision • Nov 10Consensus revenue estimates fall by 17%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from €10.3m to €8.53m. Forecast losses increased from -€10.40 to -€10.74 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 34% next year. Consensus price target down from €74.01 to €61.50. Share price fell 17% to €18.70 over the past week.Major Estimate Revision • Nov 07Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from €11.2m to €10.0m. EPS estimate unchanged from -€11.33 per share at last update. Aerospace & Defense industry in Germany expected to see average net income growth of 34% next year. Consensus price target of €71.00 unchanged from last update. Share price fell 5.8% to €22.80 over the past week.Breakeven Date Change • Jul 29Forecast breakeven date moved forward to 2023The 3 analysts covering Mynaric previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €12.0m in 2023. Average annual earnings growth of 80% is required to achieve expected profit on schedule.Price Target Changed • Jul 29Price target decreased to €71.00Down from €82.75, the current price target is an average from 3 analysts. New target price is 93% above last closing price of €36.70. Stock is down 48% over the past year. The company is forecast to post a net loss per share of €3.90 next year compared to a net loss per share of €10.70 last year.Reported Earnings • May 01Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: €10.68 loss per share (down from €5.90 loss in FY 2020). Net loss: €45.4m (loss widened 130% from FY 2020). Revenue missed analyst estimates by 79%. Earnings per share (EPS) also missed analyst estimates by 117%. Over the next year, revenue is forecast to grow 1,547%, compared to a 22% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Reported Earnings • Oct 24First half 2021 earnings released: €3.94 loss per share (vs €2.33 loss in 1H 2020)The company reported a solid first half result with improved revenues and control over costs, although losses increased. First half 2021 results: Revenue: €1.35m (up €1.26m from 1H 2020). Net loss: €16.1m (loss widened 120% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.공시 • Aug 26Mynaric AG Releases Next Generation Ultra-Fast, Scalable Optical Communications Terminal for Satellite ApplicationsMynaric AG debuted its next generation space terminal at the 36th Annual Space Symposium as part of its unwavering commitment to industrialize laser communication technology for the aerospace market. The CONDOR Mk3 will expand the company's current product portfolio by providing a mass-manufacturable, smaller, lighter and low-power option, which has evolved in response to feedback that customers and the industry have given to the new product's SDA-compliant Mk2 predecessor. The company also announced having already signed a launch customer for the newly unveiled product. The undisclosed customer is scheduled to receive initial product deliveries from fourth quarter of 2022 and has secured options for up to 20 units. Key to the Mk3's entry into the market is its scalability of both speed and production. With configurable data rate speeds between 100 Mbps and 100 Gbps, the terminal ensures both standardized compatibility with the SDA's requirements and delivers higher speeds for different missions. Additionally, Mynaric's commitment and investment to increased production capabilities in the United States and Germany ensures a scalably-manufactured terminal delivering on both short lead times and affordability. Using best-in-class design, the CONDOR Mk3 realized significant size, weight, power and performance advantages over its product predecessors, including: Optical Head mass and size reduced by 30% compared to Mk2; Optimized power consumption; Flexible data rate coverage from 100 Mbps up to 100 Gbps; Link distances beyond 7,500 km; Full compliance with SDA Tranche 0 and Tranche 1 OISL Standard in the same terminal; Adaptable to flat-panel satellite designs.Reported Earnings • Apr 09Full year 2020 earnings released: €6.78 loss per share (vs €2.77 loss in FY 2019)The company reported a mediocre full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: €10.4m (up 57% from FY 2019). Net loss: €22.7m (loss widened 191% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Mar 05New 90-day low: €64.20The company is down 2.0% from its price of €65.80 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Aerospace & Defense industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €170 per share.Is New 90 Day High Low • Feb 06New 90-day high: €84.60The company is up 51% from its price of €56.20 on 06 November 2020. The German market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Aerospace & Defense industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €171 per share.Is New 90 Day High Low • Jan 07New 90-day high: €78.60The company is up 9.0% from its price of €72.20 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €174 per share.Is New 90 Day High Low • Nov 07New 90-day low: €56.20The company is down 13% from its price of €64.60 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Aerospace & Defense industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €384 per share.Reported Earnings • Sep 23First half earnings releasedOver the last 12 months the company has reported total losses of €11.9m, with losses widening by 50% from the prior year. Total revenue was €9.80m over the last 12 months, up 185% from the prior year.공시 • Sep 10Mynaric AG to Report First Half, 2020 Results on Sep 14, 2020Mynaric AG announced that they will report first half, 2020 results on Sep 14, 2020공시 • Aug 04Mynaric AG announced that it has received €5 million in fundingMynaric AG (XTRA:M0Y) announced a private placement of a convertible bond for gross proceeds of €5,000,000 on August 3, 2020. The bond will mature on December 31, 2020. The bond will convert into shares at a fixed conversion price of EUR 56 per share. In the event of full conversion, approximately 2.9% of the current share capital would be issued. The transaction included participation from a qualified investor.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 M0YN 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: M0YN 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Mynaric 배당 수익률 vs 시장M0YN의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (M0YN)n/a시장 하위 25% (DE)1.6%시장 상위 25% (DE)4.8%업계 평균 (Aerospace & Defense)1.0%분석가 예측 (M0YN) (최대 3년)0%주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 M0YN 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 M0YN 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 M0YN 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: M0YN 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/06/12 03:23종가2025/05/30 00:00수익2023/12/31연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Mynaric AG는 3명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Austin MoellerCanaccord GenuityZafer RüzgarPareto SecuritiesJuergen WagnerStifel, Equities Research
공시 • May 01Mynaric AG announced delayed 20-F filingOn 04/30/2025, Mynaric AG announced that they will be unable to file their next 20-F by the deadline required by the SEC.
공시 • Mar 30Mynaric AG Announces Resignation of Bulent Altan as Chairman and Member of Supervisory Board Effective April 1, 2025Mynaric AG announced that Bulent Altan, on March 28, 2025, has tendered his resignation as Chairman and Member of the Supervisory Board of the Company for personal reasons effective April 1, 2025. Bulent Altan was elected Chairman of the Supervisory Board of the Company following his election as member of the Supervisory Board by the General Assembly in August 2023. The Supervisory Board of the Company will conduct a new election for the role of Chairman without undue delay. A new member will be appointed in due course in accordance with the provisions of applicable stock corporation act (Aktiengesetz).
공시 • Mar 13Rocket Lab USA, Inc. (NasdaqCM:RKLB) entered into a non-binding term sheet to acquire Mynaric AG (XTRA:M0YN) from Lenders for $150 million.Rocket Lab USA, Inc. (NasdaqCM:RKLB) entered into a non-binding term sheet to acquire Mynaric AG (XTRA:M0YN) from Lenders for $150 million on March 10, 2025. As part of the acquisition, Rocket Lab would acquire 100% of the outstanding equity interests of Mynaric and initial purchase price is expected to be $75 million payable in either cash or shares of common stock of Rocket Lab, at Rocket Lab’s option, with the potential for additional earn-out consideration based on future revenue targets of the Mynaric business of up to an additional $75 million in shares of Rocket Lab common stock or cash, at Rocket Lab’s option. The initial closing purchase price will also be increased (and the potential earnout consideration correspondingly decreased) to the extent of any additional cash investment by the Lenders or their affiliates in Mynaric after completion of the StaRUG Restructuring and before the closing of the potential acquisition. If Rocket Lab USA, Inc chooses to issue cash consideration, then the proceeds from the offering will be used to fund the acquisition. The transaction is subject to receipt of certain governmental approvals, following the completion of Mynaric’s previously announced and pending StaRUG restructuring proceedings under German law, the completion of which would result in certain outstanding debt held by the Lenders converting into 100% of the equity of Mynaric, subject to customary due diligence and signing of definitive agreement.
공시 • Mar 12Mynaric Updates on Operational Continuity and Ongoing Production and DeliveriesMynaric announced that it is continuing to ramp up production and customer deliveries of the CONDOR Mk3 optical communications terminal and updates on the background to the company’s StaRUG proceedings. The StaRUG proceedings, once completed, would provide for significant debt relief, enabling the company to continue to serve its current and potential customers, suppliers and partners. Focus on Delivering on Existing Contracts and Winning Future Opportunities: Mynaric is also continuing to pursue opportunities that explore the use of free-space optical communications for additional space programs. In addition to contributing to the U.S. Space Development Agency’s (SDA) Proliferated Warfighter Space Architecture (PWSA) Tranche 1 and Tranche 2 programs, Mynaric has also been recognized as a key development partner in multiple projects to develop quantum communication capabilities. Establishing a Stable Financial and Operational Footing Moving Forward: Mynaric’s lenders agreed to the restructuring concept on the condition that Mynaric initiates StaRUG proceedings and that the restructuring plan provides for a capital reduction to zero. To enable Mynaric to cover its expected ongoing operational and working capital until the conclusion of the StaRUG proceedings, Mynaric’s lenders committed a fourth bridge loan of USD 28 million in February 2025 as well as an additional USD 25 million restructuring loan, giving Mynaric the necessary resources to support its production plan and ongoing operations. The implementation of the financial restructuring through the StaRUG proceedings would safeguard jobs, protect creditor interests, and significantly reduce Mynaric’s cash interest burden.
공시 • Feb 18+ 1 more updateMynaric AG(NasdaqGS:MYNA) dropped from NASDAQ Composite IndexMynaric AG has been dropped from the NASDAQ Composite Index.
공시 • Feb 14Mynaric Announces Receipt of Delisting Notice from NasdaqMynaric announced that it received a delisting notification dated February 10, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market Inc. As previously disclosed, on February 7, 2025, Mynaric's management board, with the approval of its supervisory board, resolved on a financial restructuring by proceedings under the German Corporate Stabilization and Restructuring Act (Gesetz über den Stabilisierungs- und Restrukturierungsrahmen für Unternehmen) and notified the competent Munich Local Court - Restructuring Court - of such restructuring project (the "StaRUG Proceeding").On February 10, 2025, Mynaric received the Delisting Notice from Nasdaq notifying Mynaric that, as a result of the StaRUG Proceeding and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined that Mynaric's American Depositary Shares representing its ordinary shares (the "ADS") will be delisted from Nasdaq. The Delisting Notice also advises Mynaric of its right to appeal Nasdaq's determination pursuant to procedures set in the Nasdaq Listing Rule 5800 Series. Mynaric does not intend to pursue an appeal. Trading of the ADS will be suspended at the opening of business on February 18, 2025. Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission, which will remove the ADS from listing and registration on Nasdaq. Nasdaq has previously notified Mynaric that it is no longer in compliance with (i) Nasdaq Listing Rule 5450(b)(2)(A) for failing to maintain a minimum market value of $50 million in listed securities, (ii) Nasdaq Listing Rule 5250(c)(2) for not filing an interim balance sheet and income statement as of and for the end of its second quarter on Form 6-K within six months following the end of Mynaric's second quarter, (iii) Nasdaq Listing Rule 5620(a) for failing to hold an annual meeting of shareholders within twelve months after the end of the Mynaric's fiscal year, and (iv) Nasdaq Listing Rule 5450(a)(1) for not meeting the minimum closing bid price of $1.00 per share of the ADS.
New Risk • Feb 05New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.38m (US$9.77m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (36% average weekly change). Negative equity (-€49m). Market cap is less than US$10m (€9.38m market cap, or US$9.77m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Currently unprofitable and not forecast to become profitable over next 3 years (€22m net loss in 3 years).
공시 • Jan 16Mynaric AG, Annual General Meeting, Feb 21, 2025Mynaric AG, Annual General Meeting, Feb 21, 2025, at 10:00 W. Europe Standard Time.
공시 • Jan 04Mynaric AG Updates Earnings Guidance for the Full Year 2024Mynaric AG updated earnings guidance for the full year 2024. For the year, the company anticipates IFRS-15 revenue of EUR 14.1 million compared to previous guidance of a range estimating between EUR 16.0 million to EUR 24.0 million. The guidance decrease reflects shipments of CONDOR Mk3 terminals, originally expected to ship in late 2024, to slip into early 2025, due to shortages of key components from suppliers. These delays resulted in approximately EUR 2.6 million of revenue for terminals previously expected to ship in 2024 now expected to ship and revenue recognized in early 2025. Operating loss: the previous Company guidance of a range of operating loss estimating to range between a loss of EUR 55.0 million to EUR 50.0 million is unchanged.
New Risk • Dec 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Negative equity (-€49m). Market cap is less than US$10m (€7.90m market cap, or US$8.29m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€48m net loss in 2 years).
New Risk • Dec 06New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.72m (US$9.21m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Negative equity (-€49m). Market cap is less than US$10m (€8.72m market cap, or US$9.21m). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€46m net loss in 2 years).
공시 • Nov 05Mynaric AG, Annual General Meeting, Dec 11, 2024Mynaric AG, Annual General Meeting, Dec 11, 2024, at 10:00 W. Europe Standard Time.
공시 • Nov 01Bronstein, Gewirtz & Grossman, LLC Announces Class Action Lawsuit Files Against Mynaric AGBronstein, Gewirtz & Grossman, LLC announced that a class action lawsuit has been filed against Mynaric AG (Mynaric) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mynaric securities between June 20, 2024, and October 7, 2024, inclusive (Class Period). The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) lower-than-expected production yields and component supplier shortages of key components were causing production delays for Mynaric's CONDOR Mk3 product; (2) the foregoing issues were likely to have a material negative impact on the Company's revenue growth and cause the Company to incur an operating loss; (3) as a result, Mynaric was unlikely to meet its own previously issued financial guidance for fiscal year 2024; (4) accordingly, the Company's business and/or financial prospects were overstated; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times.
공시 • Oct 08Mynaric Receives Deficiency Letter from Nasdaq Regarding Non-Compliance with the Minimum Market Value of Listed SecuritiesMynaric AG announced that it received a notification letter dated October 2, 2024 (the ‘Deficiency Letter’) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the ‘Nasdaq’) notifying that Mynaric is no longer in compliance with the Nasdaq continued listing criteria, including the Nasdaq Listing Rule 5450(b)(2)(A) due to its failure to maintain a minimum of $50 million in market value of listed securities (the ‘MVLS Requirement’). Nasdaq also determined that Mynaric does not meet the alternatives of total assets and total revenue for continued listing. The Deficiency Letter has no immediate effect on the listing of Mynaric’s American Depositary Shares representing its ordinary shares (the ‘ADS’), which continue to trade under the symbol ‘MYNA.’ The Deficiency Letter provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C), Mynaric has a period of 180 calendar days from the date of the Deficiency Letter, or until March 31, 2025, to regain compliance with the MVLS Requirement. During this period, the ADS will continue to trade on Nasdaq. Nasdaq will deem Mynaric to have regained compliance with the MVLS Requirement if at any time during this compliance period Mynaric’s MVLS closes at $50,000,000 or more for a minimum of ten consecutive business days. In the event Mynaric does not regain compliance with the MVLS Requirement by March 31, 2025, Mynaric will receive written notification from Nasdaq that Mynaric’s ADS are subject to delisting. At that time, Mynaric may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance, if Mynaric does appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would be successful. In such event, Mynaric may also seek to apply for a transfer to The Nasdaq Capital Market if it meets the requirements for continued listing thereon. Mynaric is reviewing its options for regaining compliance with the MVLS Requirement and for remedying other future potential non-compliances with Nasdaq continued listing requirements. There can be no assurance that Mynaric will be able to regain compliance with the MVLS Requirement or other Nasdaq continued listing requirements in a timely fashion, in which case its securities would be delisted from Nasdaq.
공시 • Sep 17Mynaric Advances Production of CONDOR Mk3Mynaric announced the successful advancement of the company's volume production ramp for the CONDOR Mk3. Mynaric continues to work through previously announced production delays and has realized near-term improvement in production yields and supply chain-related bottlenecks. Production delays of CONDOR Mk3 were caused by lower than expected production yields and supplier shortages of key components. Current shipments of the CONDOR Mk3 free space optical communications system will be part of the United States Space Development Agency (SDA) Tranche 1 program. Mynaric was selected by Northrop Grumman as the sole supplier of optical communications terminals for the SDA's Tranche 1 Transport and Tracking Layer programs and by York Space Systems for the SDA's Tranche 1 Transport Layer. Mynaric was also selected by Loft Federal to supply the CONDOR Mk3 terminals to NExT – the SDA's Experimental Testbed. In addition, Mynaric continues to pursue opportunities that explore the use of free-space optical communications for additional space programs. Mynaric has been recognized as a key development partner in Phase 2 of DARPA's Space-BACN program, was selected by the European Space Agency (ESA) to investigate optical technologies for next generation high-throughput optical inter-satellite links and was selected by the German government for multiple projects to develop quantum communication capabilities. In addition, Mynaric continues to diligently pursue additional capital sources to secure on-going operations and production ramp.
New Risk • Sep 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -€34m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€34m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Negative equity (-€49m). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€46m net loss in 2 years). Market cap is less than US$100m (€19.6m market cap, or US$21.7m).
New Risk • Aug 30New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €94m Forecast net loss in 2 years: €46m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-€49m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-€34m). Currently unprofitable and not forecast to become profitable over next 2 years (€46m net loss in 2 years). Market cap is less than US$100m (€21.7m market cap, or US$24.1m).
공시 • Aug 27+ 1 more updateMynaric AG Announces Management ChangesThe board of Mynaric AG announced the appointment of Andreas Reif with immediate effect as member of the management board and Chief Restructuring Officer. In his role as CRO, Andreas Reif will be integral to reducing costs and near-term cash consumption while working closely with customers to meet their requirements. Prior to joining Mynaric, Andreas Reif served in executive financial and operational roles and as a key advisor forindustrial manufacturing companies throughout Germany. Mynaric announced that the supervisory board and the chief executive officer, Mustafa Veziroglu, jointly decided on the termination of the office of Mustafa Veziroglu as CEO and member of the management board of Mynaric with immediate effect.
Major Estimate Revision • Aug 23Consensus EPS estimates fall by 36%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €56.6m to €55.6m. Losses expected to increase from €7.53 per share to €10.24. Aerospace & Defense industry in Germany expected to see average net income growth of 35% next year. Consensus price target down from €31.50 to €20.40. Share price fell 68% to €4.55 over the past week.
New Risk • Aug 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-€49m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-€34m). Market cap is less than US$100m (€44.1m market cap, or US$49.1m).
공시 • Aug 20+ 1 more updateMynaric Announces Departure of Stefan Berndt Von-Bülow as CFOMynaric announced the voluntary departure of CFO Stefan Berndt von-Bülow for personal reasons, effective last week. Berndt von-Bülow has been with Mynaric since 2018 and assumed the role as CFO in 2020. As CFO, Berndt von-Bülow made significant contributions to the company's financial strategy and operations, investor relations, several capital raises, significant debt financing, and, particularly Mynaric's listing on Nasdaq in November 2021, during a time of significant growth and transformation. Mynaric has initiated a global search for a new CFO. In the interim, the two remaining members of the management team, Mustafa Veziroglu and Joachim Horwath, will assume the responsibilities of the CFO.
Price Target Changed • Jul 30Price target decreased by 29% to €31.50Down from €44.50, the current price target is an average from 2 analysts. New target price is 109% above last closing price of €15.10. Stock is down 30% over the past year. The company is forecast to post a net loss per share of €7.52 next year compared to a net loss per share of €15.48 last year.
공시 • Jul 23Mynaric AG, Annual General Meeting, Aug 29, 2024Mynaric AG, Annual General Meeting, Aug 29, 2024, at 10:00 W. Europe Standard Time.
공시 • Jun 21Mynaric Provides Earnings Guidance for the Full Year 2024Mynaric provided earnings guidance for the full year 2024. For the fiscal year 2024, revenue outlook is driven by shipments of CONDOR Mk3 units to multiple customers. This outlook assumes it is able to ramp to its current production plans. This outlook remains at the lower end of the most recent published analyst estimates for 2024 (for which the arithmetic average is approximately €65 million). The company expects its operating loss for the fiscal year 2024 to decrease significantly from last year's level due to higher revenue levels. This outlook remains in-line with the most recent published analyst estimates for 2024 (for which the arithmetic average is approximately -€36 million). The outlook is based on the current projected production ramp and current liquidity projection. Should Mynaric experience either a pushout in its production schedule, fail to secure new orders as planned or incur delays in securing new orders from customers, there is a high likelihood the company could need to raise additional capital. Mynaric is also considering pursuing multiple alternative options in order to secure its cash needs and bolster its long-term success.
공시 • Jun 14Mynaric AG to Report Fiscal Year 2023 Results on Jun 20, 2024Mynaric AG announced that they will report fiscal year 2023 results on Jun 20, 2024
공시 • May 01Mynaric AG announced delayed 20-F filingOn 04/30/2024, Mynaric AG announced that they will be unable to file their next 20-F by the deadline required by the SEC.
New Risk • Apr 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€23m net loss in 2 years). Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding).
Major Estimate Revision • Apr 14Consensus revenue estimates fall by 61%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €11.0m to €4.30m. Forecast losses increased from -€11.81 to -€13.12 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 50% next year. Consensus price target down from €42.00 to €41.00. Share price rose 10% to €18.65 over the past week.
공시 • Apr 03Mynaric Begins Volume Production for its Space Laser Terminal - CONDOR Mk3Mynaric announced a milestone in the product maturity of the company's free space optical communications terminal for space-to-space and space-to-ground applications - the CONDOR Mk3. Volume production for the optical communications terminal began early in the first quarter of 2024 with an initial shipment made last week following customer approval. Initial shipments of the CONDOR Mk3 free space optical communications system will be part of the United States Space Development Agency (SDA) Tranche 1 Transport and Tracking Layer programs, among others. Mynaric was selected by Northrop Grumman as the sole supplier of optical communications terminals for the SDA's Tranche 1 Transport and Tracking Layer programs and by York Space Systems for the SDA's Tranche 1 Transport Layer. Mynaric was also selected by Loft Federal to supply the CONDOR Mk3 terminals to NExT – the SDA's Experimental Testbed. In addition to volume production of the CONDOR Mk3 optical communications system, Mynaric continues to pursue opportunities that explore the use of free space optical communications for additional space programs. Mynaric has been recognized as a key development partner in Phase 2 of DARPA's Space-BACN program, was selected by the European Space Agency (ESA) to investigate optical technologies for next generation high-throughput optical inter-satellite links and was selected by the German government for multiple projects to develop quantum communication capabilities.
Major Estimate Revision • Dec 15Consensus revenue estimates fall by 41%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €18.5m to €11.0m. Forecast losses increased from -€10.58 to -€11.81 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 35% next year. Consensus price target of €42.00 unchanged from last update. Share price rose 31% to €24.00 over the past week.
Major Estimate Revision • Nov 19Consensus revenue estimates fall by 27%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €25.5m to €18.5m. Forecast losses increased from -€9.67 to -€10.58 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 44% next year. Consensus price target of €42.00 unchanged from last update. Share price fell 11% to €16.70 over the past week.
공시 • Nov 12Mynaric Provides Earnings Guidance for the Full Year 2023Mynaric provides earnings guidance for the full year 2023. The company now expects full-year 2023 IFRS-15 revenue to remain around the same level as 2022 revenue of EUR 4.4 million compared to previous guidance of a significant increase. The guidance decrease is due to the production delay of CONDOR Mk3 that was previously scheduled to start in fourth quarter 2023. The company now expects full-year 2023 operating loss to be around the same level as last year compared to previous guidance of a moderate decrease relative to the EUR 73.8 million operating loss reported for full-year 2022.
New Risk • Oct 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.5% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€25m net loss in 2 years). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (€89.1m market cap, or US$94.4m).
New Risk • Oct 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.1m (US$94.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€25m net loss in 2 years). Share price has been volatile over the past 3 months (7.5% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (€90.1m market cap, or US$94.9m).
Reported Earnings • Sep 17First half 2023 earnings released: €5.55 loss per share (vs €6.28 loss in 1H 2022)First half 2023 results: €5.55 loss per share (improved from €6.28 loss in 1H 2022). Net loss: €32.4m (loss narrowed 1.4% from 1H 2022). Revenue is forecast to grow 53% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Aerospace & Defense industry in Germany. Over the last 3 years on average, earnings per share has fallen by 34% per year whereas the company’s share price has fallen by 39% per year.
New Risk • Sep 15New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €73m Forecast net loss in 2 years: €21m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€21m net loss in 2 years). Share price has been volatile over the past 3 months (6.2% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding).
공시 • Sep 08Mynaric AG to Report First Half, 2023 Results on Sep 14, 2023Mynaric AG announced that they will report first half, 2023 results on Sep 14, 2023
Price Target Changed • Sep 07Price target decreased by 21% to €36.67Down from €46.67, the current price target is an average from 3 analysts. New target price is 101% above last closing price of €18.20. Stock is down 36% over the past year. The company is forecast to post a net loss per share of €9.28 next year compared to a net loss per share of €13.57 last year.
공시 • Aug 09Mynaric Announces Executive ChangesMynaric announced key results of the company's annual general assembly held on August 7, 2023. Following shareholder approval, industry veterans Bulent Altan and Margaret Abernathy joined Mynaric's Supervisory Board after receiving the requisite number of votes during the annual general assembly. They join the three re-elected Supervisory Board members: Dr. Hans Königsmann, Dr. Manfred Krischke, and Peter Müller-Brühl, effective immediately. Following the company's annual general assembly meeting, the Supervisory Board met and elected Bulent Altan as Chairman. Mustafa Veziroglu will serve as the company's Chief Executive Officer. Veziroglu will lead Mynaric's day-to-day business operations and strategy to produce laser communications terminals at scale for applications in space, air and terrestrial applications.
공시 • Jul 01Mynaric AG, Annual General Meeting, Aug 07, 2023Mynaric AG, Annual General Meeting, Aug 07, 2023, at 10:00 Central European Standard Time. Location: Haus der Bayrischen Wirtschaft, Max-Joseph-Strasse 5, 80333 Munich, Germany Munich Germany Agenda: To consider Annual Financial Statement as of December 31, 2022; to consider Curriculum vitae of the candidates proposed for election to the Supervisory Board; and to consider other business matters.
공시 • May 12+ 1 more updateMynaric Ag Announces Resignation of Mr. Altan as A Member of the Management BoardMynaric AG announced that Mr. Altan will resign from his position as member of the Management Board of Mynaric AG as of the end of the Annual General Meeting 2023 of the Company at the beginning of Third Quarter 2023.
Price Target Changed • May 03Price target decreased by 13% to €51.17Down from €59.00, the current price target is an average from 3 analysts. New target price is 105% above last closing price of €24.90. Stock is down 30% over the past year. The company is forecast to post earnings per share of €2.94 next year compared to a net loss per share of €13.57 last year.
Breakeven Date Change • May 01Forecast breakeven date moved forward to 2023The 4 analysts covering Mynaric previously expected the company to break even in 2025. New consensus forecast suggests the company will make a profit of €12.0m in 2023. Earnings growth of 44% is required to achieve expected profit on schedule.
공시 • Feb 01+ 1 more updateMynaric AG Appoints Mustafa Veziroglu as Co-CEO, Effective February 1, 2023Mynaric, AG announced the appointment of Mustafa Veziroglu as Co-CEO of the company, effective February 1, 2023. Mustafa Veziroglu joined Mynaric in August 2022 as President and since then has been responsible for all operational product-related activities within Mynaric overseeing the entire product lifecycle from development through delivery. With Mynaric's recent success in winning additional new customers and hitting important customer milestones, his role as Co-CEO will be to strengthen Mynaric's focus on 2023 execution targets and jointly lead the company with Co-CEO Bulent Altan.
Major Estimate Revision • Jan 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €2.26m to €2.99m. EPS estimate unchanged at -€11.66. Aerospace & Defense industry in Germany expected to see average net income growth of 43% next year. Consensus price target down from €59.00 to €52.00. Share price rose 11% to €15.30 over the past week.
Major Estimate Revision • Nov 25Consensus revenue estimates fall by 56%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from €5.13m to €2.24m. Forecast losses increased from -€11.33 to -€11.54 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 42% next year. Consensus price target of €59.00 unchanged from last update. Share price was steady at €16.80 over the past week.
Price Target Changed • Nov 16Price target decreased to €59.00Down from €71.00, the current price target is an average from 4 analysts. New target price is 249% above last closing price of €16.90. Stock is down 75% over the past year. The company is forecast to post a net loss per share of €3.90 next year compared to a net loss per share of €10.70 last year.
Breakeven Date Change • Nov 16Forecast to breakeven in 2023The 3 analysts covering Mynaric expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of €12.0m in 2023. Average annual earnings growth of 50% is required to achieve expected profit on schedule.
Major Estimate Revision • Nov 10Consensus revenue estimates fall by 17%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from €10.3m to €8.53m. Forecast losses increased from -€10.40 to -€10.74 per share. Aerospace & Defense industry in Germany expected to see average net income growth of 34% next year. Consensus price target down from €74.01 to €61.50. Share price fell 17% to €18.70 over the past week.
Major Estimate Revision • Nov 07Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from €11.2m to €10.0m. EPS estimate unchanged from -€11.33 per share at last update. Aerospace & Defense industry in Germany expected to see average net income growth of 34% next year. Consensus price target of €71.00 unchanged from last update. Share price fell 5.8% to €22.80 over the past week.
Breakeven Date Change • Jul 29Forecast breakeven date moved forward to 2023The 3 analysts covering Mynaric previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €12.0m in 2023. Average annual earnings growth of 80% is required to achieve expected profit on schedule.
Price Target Changed • Jul 29Price target decreased to €71.00Down from €82.75, the current price target is an average from 3 analysts. New target price is 93% above last closing price of €36.70. Stock is down 48% over the past year. The company is forecast to post a net loss per share of €3.90 next year compared to a net loss per share of €10.70 last year.
Reported Earnings • May 01Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: €10.68 loss per share (down from €5.90 loss in FY 2020). Net loss: €45.4m (loss widened 130% from FY 2020). Revenue missed analyst estimates by 79%. Earnings per share (EPS) also missed analyst estimates by 117%. Over the next year, revenue is forecast to grow 1,547%, compared to a 22% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Reported Earnings • Oct 24First half 2021 earnings released: €3.94 loss per share (vs €2.33 loss in 1H 2020)The company reported a solid first half result with improved revenues and control over costs, although losses increased. First half 2021 results: Revenue: €1.35m (up €1.26m from 1H 2020). Net loss: €16.1m (loss widened 120% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
공시 • Aug 26Mynaric AG Releases Next Generation Ultra-Fast, Scalable Optical Communications Terminal for Satellite ApplicationsMynaric AG debuted its next generation space terminal at the 36th Annual Space Symposium as part of its unwavering commitment to industrialize laser communication technology for the aerospace market. The CONDOR Mk3 will expand the company's current product portfolio by providing a mass-manufacturable, smaller, lighter and low-power option, which has evolved in response to feedback that customers and the industry have given to the new product's SDA-compliant Mk2 predecessor. The company also announced having already signed a launch customer for the newly unveiled product. The undisclosed customer is scheduled to receive initial product deliveries from fourth quarter of 2022 and has secured options for up to 20 units. Key to the Mk3's entry into the market is its scalability of both speed and production. With configurable data rate speeds between 100 Mbps and 100 Gbps, the terminal ensures both standardized compatibility with the SDA's requirements and delivers higher speeds for different missions. Additionally, Mynaric's commitment and investment to increased production capabilities in the United States and Germany ensures a scalably-manufactured terminal delivering on both short lead times and affordability. Using best-in-class design, the CONDOR Mk3 realized significant size, weight, power and performance advantages over its product predecessors, including: Optical Head mass and size reduced by 30% compared to Mk2; Optimized power consumption; Flexible data rate coverage from 100 Mbps up to 100 Gbps; Link distances beyond 7,500 km; Full compliance with SDA Tranche 0 and Tranche 1 OISL Standard in the same terminal; Adaptable to flat-panel satellite designs.
Reported Earnings • Apr 09Full year 2020 earnings released: €6.78 loss per share (vs €2.77 loss in FY 2019)The company reported a mediocre full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: €10.4m (up 57% from FY 2019). Net loss: €22.7m (loss widened 191% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Mar 05New 90-day low: €64.20The company is down 2.0% from its price of €65.80 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Aerospace & Defense industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €170 per share.
Is New 90 Day High Low • Feb 06New 90-day high: €84.60The company is up 51% from its price of €56.20 on 06 November 2020. The German market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Aerospace & Defense industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €171 per share.
Is New 90 Day High Low • Jan 07New 90-day high: €78.60The company is up 9.0% from its price of €72.20 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €174 per share.
Is New 90 Day High Low • Nov 07New 90-day low: €56.20The company is down 13% from its price of €64.60 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Aerospace & Defense industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €384 per share.
Reported Earnings • Sep 23First half earnings releasedOver the last 12 months the company has reported total losses of €11.9m, with losses widening by 50% from the prior year. Total revenue was €9.80m over the last 12 months, up 185% from the prior year.
공시 • Sep 10Mynaric AG to Report First Half, 2020 Results on Sep 14, 2020Mynaric AG announced that they will report first half, 2020 results on Sep 14, 2020
공시 • Aug 04Mynaric AG announced that it has received €5 million in fundingMynaric AG (XTRA:M0Y) announced a private placement of a convertible bond for gross proceeds of €5,000,000 on August 3, 2020. The bond will mature on December 31, 2020. The bond will convert into shares at a fixed conversion price of EUR 56 per share. In the event of full conversion, approximately 2.9% of the current share capital would be issued. The transaction included participation from a qualified investor.